Scopulariopsis brevicaulis, a Fungal Pathogen Resistant to Broad-Spectrum Antifungal Agents

AUTOR(ES)

Cuenca-Estrella, Manuel

FONTE

American Society for Microbiology

RESUMO

The antifungal susceptibility results for 32 clinical isolates of Scopulariopsis brevicaulis are presented. Flucytosine and itraconazole were inactive in vitro, and MICs of amphotericin B, voriconazole, and terbinafine for all isolates were high, with geometric means of 13, 25.8, and 14.4 μg/ml, respectively.

Documentos Relacionados

• Treatment with a Broad-Spectrum Cephalosporin versus Piperacillin-Tazobactam and the Risk for Isolation of Broad-Spectrum Cephalosporin-Resistant Enterobacter Species
• A case of fungal keratitis caused by Scopulariopsis brevicaulis: treatment with antifungal agents and penetrating keratoplasty.
• Cefadroxil, a New Broad-Spectrum Cephalosporin
• Peptide-mediated broad-spectrum plant resistance to tospoviruses
• Treatment of murine pulmonary blastomycosis with SCH 51048, a broad-spectrum triazole antifungal agent.